Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Genomic profiling may reveal new drug targets in urothelial carcinoma

Dr Jeffrey Ross - Albany Medical College, Albany, USA
Genomic profiling may reveal new drug targets in urothelial carcinoma ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )
27 Feb 2015

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer

Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015

When and whether to conduct endocrine therapy in non-metastatic prostate cancer

Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark
When and whether to conduct endocrine therapy in non-metastatic prostate cancer ( Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark )
27 Feb 2015

High BMI beneficial in kidney cancer

Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA
High BMI beneficial in kidney cancer ( Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA )
27 Feb 2015

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer

Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015

New approach to prostate cancer screening

Dr Sanoj Punnen - University of Miami, Miami, USA
New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )
27 Feb 2015

Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer

Dr Scott Tyldesley - British Columbia Cancer Agency, Vancouver, Canada
Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer ( Dr Scott Tyldesley - British Columbia Cancer Agency, Vancouver, Canada )
26 Feb 2015

Combination of pazopanib and paclitaxel safe in urothelial cancer

Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA
Combination of pazopanib and paclitaxel safe in urothelial cancer ( Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA )
26 Feb 2015

Tackling renal cancer with a combination of autologous immunotherapy and sunitinib

Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA
Tackling renal cancer with a combination of autologous immunotherapy and sunitinib ( Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA )
26 Feb 2015

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Prof Thomas Powles - Barts Health, London, UK
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer ( Prof Thomas Powles - Barts Health, London, UK )
26 Feb 2015

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015